José Ángel
Pérez Rivera
Investigador en el periodo 2011-2014
Publicaciones (13) Publicaciones de José Ángel Pérez Rivera
2022
-
Differences According to Age in the Diagnostic Performance of Cardiac Biomarkers to Predict Frailty in Patients with Acute Heart Failure
Biomolecules, Vol. 12, Núm. 2
-
Genetic susceptibility to telomere shortening through the rs2293607 polymorphism is associated with a greater risk of alcohol use disorder
Mechanisms of ageing and development, Vol. 206, pp. 111693
-
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT)
European heart journal. Cardiovascular pharmacotherapy, Vol. 8, Núm. 3, pp. 291-301
2020
-
Prognostic Value of Late Gadolinium Enhancement for the Prediction of Cardiovascular Outcomes in Dilated Cardiomyopathy: An International, Multi-Institutional Study of the MINICOR Group
Circulation: Cardiovascular Imaging, Vol. 13, Núm. 4, pp. E010105
2016
-
Brain natriuretic peptide levels variation after left atrial appendage occlusion
Catheterization and Cardiovascular Interventions, Vol. 87, Núm. 1, pp. E39-E43
2015
-
Device embolisation after transcatheter paravalvular leak closure
EuroIntervention
-
Recurrent syncope after left atrial appendage occlusion
Catheterization and Cardiovascular Interventions, Vol. 85, Núm. 2, pp. E58-E62
-
The role of the TERC-63G>A and TERT-1327C>T telomerase polymorphisms in the study of men with acute coronary syndrome
Minerva Cardioangiologica, Vol. 63, Núm. 6, pp. 467-474
2014
-
Effect of telomere length on prognosis in men with acute coronary syndrome
American Journal of Cardiology, Vol. 113, Núm. 3, pp. 418-421
-
Significance of the learning curve in left atrial appendage occlusion with two different devices
Catheterization and Cardiovascular Interventions, Vol. 83, Núm. 4, pp. 642-646
2013
-
A 50-year old male smoker and obese with exertional dyspnea and muscle weakness of 2 months of evolution
Medicine (Spain), Vol. 11, Núm. 35
2012
-
Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome
Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Núm. 11, pp. 1483-1493
-
Prognostic value of telomere length in acute coronary syndrome
Mechanisms of Ageing and Development, Vol. 133, Núm. 11-12, pp. 695-697